Skip to main content

Advertisement

SpringerLink
Log in

Increase in the Tight Junction Protein Claudin-1 in Intestinal Inflammation

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background and Aims

Studies have shown a decrease in key tight junction (TJ) proteins such as ZO-1 and occludin in both inflammatory bowel disease (IBD) and experimental models of inflammation. Our group has also shown an increase in claudin-1 in experimental colitis.

Methods

IEC-18 cells were treated with increasing doses of tumor necrosis factor alpha (TNFα). The TJ was assessed by transepithelial resistance (TER), permeability, Western blot, PCR, and immunofluorescence. Mucosal samples from patients with ulcerative colitis (UC), Crohn’s disease (CD), and without IBD (normal) were assayed for TJ proteins occludin and claudin-1 by Western blot and a ratio of claudin-1 to occludin (C:O) was calculated.

Results

IEC-18 cells had increased permeability, decreased TER and an increase in claudin-1 with TNFα treatment. In human specimens, there was a decrease in occludin and an increase in claudin-1 leading to a significant increase in the C:O ratio in diseased UC colon compared to non-diseased UC colon (P < 0.001) and normal colon (P < 0.01). In CD, the C:O ratio was similar in all CD tissue irrespective of disease status.

Conclusions

Treatment of IEC-18 cells with TNFα, a key inflammatory cytokine in IBD, led to a significant increase in claudin-1 expression. There was a significant increase in the C:O ratio in diseased colon in UC compared to the healthy appearing UC colon and normal controls. The C:O ratio was unchanged in CD despite presence or abscence of gross disease. This suggests that there may be an underlying difference in the TJ between UC and CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol. 1990;81:301–305.

    Article  PubMed  CAS  Google Scholar 

  2. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut. 1993;34:1705–1709.

    Article  PubMed  CAS  Google Scholar 

  3. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995;101:428–435.

    Article  PubMed  CAS  Google Scholar 

  4. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998;273:29745–29753.

    Article  PubMed  CAS  Google Scholar 

  5. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol. 1999;147:1351–1363.

    Article  PubMed  CAS  Google Scholar 

  6. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993;123:1777–1788.

    Google Scholar 

  7. Matter K, Balda MS. Occludin and the functions of tight junctions. Int Rev Cytol. 1999;186:117–146.

    Article  PubMed  CAS  Google Scholar 

  8. Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol. 2006;68:403–429. doi:10.1146/annurev.physiol.68.040104.131404.

    Article  PubMed  Google Scholar 

  9. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998;141:1539–1550.

    Article  PubMed  CAS  Google Scholar 

  10. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol. 2001;281:G216–G228.

    PubMed  CAS  Google Scholar 

  11. Marin ML, Greenstein AJ, Geller SA, Gordon RE, Aufses AH Jr. A freeze fracture study of Crohn’s disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol. 1983;78:537–547.

    PubMed  CAS  Google Scholar 

  12. Olson TS, Reuter BK, Scott KG, et al. The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med. 2006;203:541–552. doi:10.1084/jem.20050407.

    Google Scholar 

  13. Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res. 2007;140:12–19. doi:10.1016/j.jss.2006.07.050.

    Google Scholar 

  14. Resta-Lenert S, Smitham J, Barrett KE. Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice. Am J Physiol Gastrointest Liver Physiol. 2005;289:G153–G162. doi:10.1152/ajpgi.00395.2004.

  15. Reuter BK, Pizarro TT. Mechanisms of tight junction dysregulation in the SAMP1/YitFc model of Crohn’s disease-like ileitis. Ann N Y Acad Sci. 2009;1165:301–307. doi:10.1111/j.1749-6632.2009.04035.x.

    Article  PubMed  CAS  Google Scholar 

  16. Schmitz H, Barmeyer C, Fromm M, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999;116:301–309.

    Google Scholar 

  17. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159:2001–2009.

    Article  PubMed  CAS  Google Scholar 

  18. Oshima T, Miwa H, Joh T. Changes in the expression of claudins in active ulcerative colitis. J Gastroenterol Hepatol. 2008;23:S146–S150. doi:10.1111/j.1440-1746.2008.05405.x.

  19. Poritz L, Sundstrom J, Harris L, Barber A, Antonetti D. Alteration of occludin expression in intestinal inflammation. J Surg Res. 2009;151:188.

    Google Scholar 

  20. Ma TY, Iwamoto GK, Hoa NT, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 2004;286:G367–G376. doi:10.1152/ajpgi.00173.2003.

    Google Scholar 

  21. Soler AP, Marano CW, Bryans M, et al. Activation of NF-kappaB is necessary for the restoration of the barrier function of an epithelium undergoing TNF-alpha-induced apoptosis. Eur J Cell Biol. 1999;78:56–66.

    PubMed  CAS  Google Scholar 

  22. Schmitz H, Fromm M, Bentzel CJ, et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci. 1999;112:137–146.

    PubMed  CAS  Google Scholar 

  23. Yoo J, Nichols A, Song JC, et al. Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes. Am J Physiol Gastrointest Liver Physiol. 2003;284:G703–G712. doi:10.1152/ajpgi.00214.2002.

    Google Scholar 

  24. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC, Jr. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem. 2002;80:667–677.

    Google Scholar 

  25. Youakim A, Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol. 1999;276:G1279–G1288.

    Google Scholar 

  26. Inai T, Kobayashi J, Shibata Y. Claudin-1 contributes to the epithelial barrier function in MDCK cells. Eur J Cell Biol. 1999;78:849–855.

    PubMed  CAS  Google Scholar 

  27. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn’s disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986;105:883–885.

    Google Scholar 

  28. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn’s disease? Gastroenterology. 1993;104:1627–1632.

    Google Scholar 

  29. Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn’s disease. Gastroenterology. 1997;113:802–807.

    Google Scholar 

  30. Koltun WA, Tilberg AF, Page MJ, Poritz LS. Bowel permeability is improved in Crohn’s disease after ileocolectomy. Dis Colon Rectum. 1998;41:687–690.

    Article  PubMed  CAS  Google Scholar 

  31. Zeissig S, Bojarski C, Buergel N, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn’s disease by tumour necrosis factor alpha antibody treatment. Gut. 2004;53:1295–1302. doi:10.1136/gut.2003.036632.

    Google Scholar 

  32. Zeissig S, Burgel N, Gunzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut. 2007;56:61–72. doi:10.1136/gut.2006.094375.

    Google Scholar 

  33. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 2000;14:1749–1753.

    Article  PubMed  CAS  Google Scholar 

  34. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003;171:6164–6172.

    PubMed  CAS  Google Scholar 

  35. Strater J, Wellisch I, Riedl S, et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology. 1997;113:160–167.

    Google Scholar 

  36. Di Sabatino A, Ciccocioppo R, Cinque B, et al. Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease. Gut. 2004;53:70–77.

    Article  PubMed  CAS  Google Scholar 

  37. Lugering A, Schmidt M, Lugering N, Pauels HG, Domschke W, Kucharzik T. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn’s disease by using a caspase-dependent pathway. Gastroenterology. 2001;121:1145–1157.

    Google Scholar 

  38. ten Hove T, van Montfrans C, Peppelenbosch MP, van Deventer SJ. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn’s disease. Gut. 2002;50:206–211.

    Article  PubMed  CAS  Google Scholar 

  39. Huo Q, Kinugasa T, Wang L, et al. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res. 2009;29:851–857.

    Google Scholar 

  40. Kinugasa T, Huo Q, Higashi D, et al. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res. 2007;27:3729–3734.

    Google Scholar 

  41. Mees ST, Mennigen R, Spieker T, et al. Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin. Int J Colorectal Dis. 2009;24:361–368. doi:10.1007/s00384-009-0653-y.

    Google Scholar 

  42. Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88:1110–1120. doi:10.1038/labinvest.2008.78.

Download references

Acknowledgments

Presented at Digestive Disease Week, May 2009.

Grant support

NIH: K08 GM081595 (Poritz).

Author information

Authors and Affiliations

  1. Division of Colon and Rectal Surgery, Department of Surgery, The Milton S. Hershey Medical Center, H137, 500 University Drive, Hershey, PA, 17033, USA

    Lisa S. Poritz, Leonard R. Harris III, Ashley A. Kelly & Walter A. Koltun

  2. Department of Cellular and Molecular Physiology, The Milton S. Hershey Medical Center, Hershey, PA, 17033, USA

    Lisa S. Poritz

Authors
  1. Lisa S. Poritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leonard R. Harris III
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashley A. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Walter A. Koltun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa S. Poritz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poritz, L.S., Harris, L.R., Kelly, A.A. et al. Increase in the Tight Junction Protein Claudin-1 in Intestinal Inflammation. Dig Dis Sci 56, 2802–2809 (2011). https://doi.org/10.1007/s10620-011-1688-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-011-1688-9

Keywords

Search

Navigation